The effect of cavinton on the systemic (by the method of diluting Evans blue according to Stewart-Hamilton) and cerebral (by the method of rheoencephalography) hemodynamics was examined in 38 patients with chronic insufficiency of the cerebral circulation (CICC) in the presence of either atherosclerosis alone (n = 22) and its combination with arterial hypertension (n = 16). Cavinton decreased the peripheral vascular resistance and the tone of the small and median vessels of the brain, increased the cardiac output and improved the rheological properties of the blood (it lowered the globular volume, viscosity and hematocrit). The best results were attained with the parenteral administration of the drug. Indications for and contraindications to cavinton in patients with CICC are discussed.
Download full-text PDF |
Source |
---|
Int J Biol Macromol
December 2023
Basic Science Research Center (Off-Campus), KLE College of Pharmacy, Bengaluru, Karnataka, India; Department of Pharmacology, KLE College of Pharmacy, Bengaluru, Karnataka, India.
Vinpocetine (VIN), a derivative of vincamine found in the vinca plant, widens blood vessels in the brain and has been shown to improve cognitive function, memory, and cerebrovascular disorders. Nevertheless, the clinical utility of VIN is constrained by factors such as low oral bioavailability owing to the first-pass metabolism that often demands frequent dosing of 3-4 tablets/day. In this regard, the present work aimed to develop VIN-loaded chitosan nanoparticles (VIN-CH-NPs) to surmount these limitations and in view to enhance delivery to the brain of VIN by minimizing systemic exposure.
View Article and Find Full Text PDFVestn Otorinolaringol
September 2022
Ulyanov Chuvash State University, Cheboksary, Russia.
Objective: To study reflexes coming from the chemoreceptors in the humoral-isolated vertebral artery zone on systemic arterial pressure, cerebral and intra-ear hemodynamics in separate stimulation with angioprotectors.
Results: A more pronounced reflex depression of the above-described effectors was caused by Nicergoline, it was less pronounced when using Vinpocetine and Pentoxifylline. Correlation analysis in doing so of the dynamics of arterio-venular coefficient of bulbar conjunctiva vessels and the membrane of the ears labyrinth round window revealed a direct relationship.
Heliyon
August 2022
BioCentre, HAN University of Applied Sciences, 6525EM, Nijmegen, the Netherlands.
Obesity is one of the most common global health problems for all age groups with obese people at risk of a variety of associated health complications. Consequently, there is a need to develop new therapies that lower body fat without the side effects. However, obesity is a complex and systemic disease, so that results are not easily translatable to clinical situations.
View Article and Find Full Text PDFAAPS PharmSciTech
November 2020
Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Non-invasive brain therapy for chronic neurological disorders is in high demand. Vinpocetine (VIN) tablets for cerebrovascular degenerative disorders ensued < 7% oral bioavailability. The olfactory pathway (providing direct brain access) can improve VIN pharmacokinetic/pharmacodynamic profile.
View Article and Find Full Text PDFClin Sci (Lond)
November 2020
Aab Cardiovascular Research Institute, University of Rochester, School of Medicine and Dentistry, Rochester, NY 14642, U.S.A.
Abdominal aortic aneurysm (AAA), commonly occurring in the aged population, is a degenerative disease that dilate and weaken infrarenal aorta due to progressive degeneration of aortic wall integrity. Vinpocetine, a derivative of alkaloid vincamine, has long been used for cerebrovascular disorders and cognitive impairment in the aged population. Recent studies have indicated that vinpocetine antagonizes occlusive vascular disorders such as intimal hyperplasia and atherosclerosis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!